Mind Medicine (MindMed) (NASDAQ:MNMD) Now Covered by Analysts at Robert W. Baird
Research analysts at Robert W. Baird started coverage on shares of Mind Medicine (MindMed) (NASDAQ:MNMD – Get Free Report) in a research note issued to investors on Tuesday, Benzinga reports. The brokerage set an “outperform” rating and a $27.00 price target on the stock. Robert W. Baird’s price target would indicate a potential upside of […]